Lv1
10 积分 2025-04-21 加入
Management of Hemangioma of Infancy: Review of 245 Patients
39分钟前
待确认
Discovery of the Potent and Highly Selective PARP7 Inhibitor as a Novel Immunotherapeutic Agent for Tumors
7个月前
已完结
Design, Synthesis, and Structure–Activity Relationship of Novel Pyridazinone-Based PARP7/HDACs Dual Inhibitors for Elucidating the Relationship between Antitumor Immunity and HDACs Inhibition
7个月前
已完结
Discovery of tricyclic PARP7 inhibitors with high potency, selectivity, and oral bioavailability
7个月前
已完结
Discovery of highly potent PARP7 inhibitors for cancer immunotherapy
7个月前
已完结
Discovery of Highly Selective PARP7 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
7个月前
已完结
PARP7i Clinical Candidate RBN‐2397 Exerts Antiviral Activity by Modulating Interferon‐β Associated Innate Immune Response in Macrophages
7个月前
已完结
皖公网安备34019202002308
